Methoctramine, a selective M2 alpha muscarinic receptor antagonist, does not inhibit carbachol-induced drinking in the rat

Eur J Pharmacol. 1989 Apr 25;163(2-3):387-91. doi: 10.1016/0014-2999(89)90213-6.

Abstract

Methoctramine, a selective M2 alpha muscarinic receptor antagonist, was examined for its ability to inhibit carbachol-induced drinking in the rat. Intracerebroventricularly (i.c.v.) administered methoctramine was devoid of activity up to a dose of 100 nmol/rat, whereas higher doses were toxic under our experimental conditions. 4-DAMP, pirenzepine and hexahydrosiladifenidol were also tested. The rank potency order for the compounds (4-DAMP greater than pirenzepine = hexahydrosiladifenidol) was similar to that for their affinity at M1 receptors, as found in experiments in vitro. The putative M1 agonist McN-A-343 was inactive up to doses of 13.9 micrograms/rat. Our data suggest that M2 alpha receptors do not mediate cholinergic drinking in the rat. The question whether M1 or M2 beta muscarinic receptors are involved in this response still awaits a firm answer.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin II / pharmacology
  • Animals
  • Carbachol / pharmacology*
  • Diamines / pharmacology*
  • Dose-Response Relationship, Drug
  • Drinking / drug effects*
  • Injections, Intraventricular
  • Male
  • Parasympatholytics / pharmacology*
  • Rats
  • Rats, Inbred Strains

Substances

  • Diamines
  • Parasympatholytics
  • Angiotensin II
  • Carbachol
  • methoctramine